Industry reports
Editor highlights

Pharmaceutical Industry Market Research Reports in North America, April 2014

You might be interested in: drug, clinical trial, vaccine, more »

» View Public Reports

1-30 of 89 reports

PDL BioPharma Inc. - Company Report for Year 2014

  • Company report
  • April 2014
  • 2 pages
  • by Corporation

... In all other global markets. Kaleo expects to launch evzio in the us later this year. Evzio is approved for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and ...

  • Industries: Drug and Medication
  • Countries: United States, Canada, North America

Company Report: Pathology for Year 2014

  • Company report
  • January 2014
  • 4 pages
  • by Corporation

... Antitrypsin (aat) for the treatment of aat deficiency liver disease; aln-tmp, an rnai therapeutic targeting tmprss6 for the treatment of beta-thalassemia and iron-overload disorders; and aln ...

  • Industries: Pathology
  • Countries: World, North America, Europe

Pharmaceutical Market in Norway and North America

  • Industry report
  • December 2013
  • 37 pages

... Injuries - 7 6. Hiv/aids- 6 7. Hypertension - 6 obesity related = 57% adult overweight/obesity trends in the caribbean mortality from coronary heart disease in norway policy ...

  • Industries: Pathology
  • Countries: Jamaica, Norway, North America

Company Report: Drug and Medication in Germany and North America for Year 2013

  • Company report
  • April 2013
  • 2 pages
  • Industries: Drug and Medication
  • Countries: Germany, North America, United States

Company Report: Drug Discovery and Development in The United States for Year 2013

  • Company report
  • April 2013
  • 85 pages

... Software that performs computer aided drug design and database tools such as cheminformatics or , used to store vast numbers of possible drug compounds during the screening process, fall ...

  • Industries: Drug Discovery and Development
  • Countries: North America, World, United States

Company Report: Drug and Medication for Year 2012

  • Company report
  • December 2012
  • 7 pages

... And international medical returning to positive internal growth in local currencies, both excluding the impact of the extra week. We sold approximately 1.4 Million doses of influenza vaccine during the quarter ...

  • Industries: Drug and Medication
  • Countries: World, North America

Company Report: Drug and Medication for Year 2012

  • Company report
  • December 2012
  • 7 pages

... And international medical returning to positive internal growth in local currencies, both excluding the impact of the extra week. We sold approximately 1.4 Million doses of influenza vaccine during the quarter ...

  • Industries: Drug and Medication
  • Countries: World, North America

Company Report: Pathology in North America for Year 2012

  • Company report
  • November 2012
  • 3 pages
  • by Corporation

... Characterized for safety, consistency and potency. Athersys has forged strategic partnerships with pfizer inc. To develop multistem for inflammatory bowel disease and with rti biologics, inc. To develop cell ...

  • Industries: Pathology
  • Countries: United States, North America

Medidata Solutions Inc. - Company Report for Year 2012

  • Company report
  • November 2012
  • 2 pages
  • by Corporation

... Development solutions that enhance the efficiency of customers' clinical trials. Medidata's advanced platform lowers the total cost of clinical development by optimizing clinical trials from concept ...

  • Industries: Drug Discovery and Development
  • Countries: North America

Company Report: Influenza Vaccine for Year 2012

  • Company report
  • November 2012
  • 7 pages
  • Industries: Drug and Medication
  • Countries: World, North America

Trius Therapeutics Inc. - Company Report for Year 2012

  • Company report
  • November 2012
  • 2 pages
  • by Corporation
  • Industries: Pharmaceutical
  • Countries: United States, North America

Company Report: Drug and Medication in The United States for Year 2012

  • Company report
  • November 2012
  • 22 pages

... Although profitability was higher. In order to provide more meaningful commentary the company will be discussing sales results including and excluding this impact. Excluding sales of seasonal influenza ...

  • Industries: Drug and Medication
  • Countries: World, North America, United States

Pharmaceutical Sector in North America

  • Industry report
  • October 2012
  • 36 pages

... Medicines agency, annual report 2011: overview of the agency s contribution to science, medicines and health in the european union, 22 march 2012. 6 K i kaitin, j a dimasi. pharmaceutical innovation ...

  • Industries: Pharmaceutical
  • Countries: Canada, United States, North America

Pharmaceutical Industry in North America

  • Industry report
  • September 2012
  • 30 pages

... Being familiar with the published literature on pca3 testing for prostate cancer Less than 20% reported that the requirement for a digital rectal exam prior to a urine collection would limit ...

  • Industries: Pathology
  • Countries: Canada, United States, North America

Prostate Cancer Business (prostate cancer, colorectal cancer, colon cancer) in North America

  • Industry report
  • June 2012
  • 29 pages

... N engl j med;366:981- 90. Multiple studies show that early diagnosis is critical to reduce risk of prostate cancer death 38% relative risk reduction at 11y risk of prostate cancer death ...

  • Industries: Pathology
  • Countries: Canada, United States, North America

Company Report: Pathology in Australia and North America for Year 2012

  • Company report
  • May 2012
  • 3 pages
  • by Market Research Publisher

... To the company S future. If the marketing of bioniche S bladder cancer drug (urocidin ) Is successful, then the shares at current prices are substantially undervalued. For more on bioniche, see e ...

  • Industries: Pathology
  • Countries: Canada, Australia, North America

Company Report: Pathology in Australia and North America for Year 2012

  • Company report
  • May 2012
  • 3 pages

... To the company S future. If the marketing of bioniche S bladder cancer drug (urocidin ) Is successful, then the shares at current prices are substantially undervalued. For more on bioniche, see e ...

  • Industries: Pathology
  • Countries: Canada, Australia, North America

Mylan Inc. - Company Report for Year 2012

  • Company report
  • April 2012
  • 8 pages
  • by Corporation
  • Industries: Pathology
  • Countries: North America, United States, World

Mylan Inc. - Company Report for Year 2012

  • Company report
  • April 2012
  • 8 pages
  • by Corporation
  • Industries: Pathology
  • Countries: North America, United States, World

Company Report: Rnai Therapeutics in North America for Year 2012

  • Company report
  • January 2012
  • 12 pages
  • by Corporation

... For physiology or medicine. rnai therapeutics, such as "sirnas," require delivery technology to be effective systemically. Tekmira believes its lnp technology represents the most widely adopted delivery ...

  • Industries: Therapy
  • Countries: United States, Canada, North America

Company Report: Pathology in North America for Year 2012

  • Company report
  • January 2012
  • 9 pages

... As well as those with high levels of blood fat and blood pressure and those who are overweight. How are diabetic neuropathies diagnosed Doctors diagnose neuropathy on the basis of symptoms ...

  • Industries: Pathology
  • Countries: United States, Canada, North America

Mylan Inc. - Investment Analysis, December 2011

  • Company report
  • December 2011
  • 8 pages

... To register and download or install any necessary software. About mylan mylan inc. Ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers ...

  • Industries: Pharmaceutical
  • Countries: United States, North America, World

Cardiome Pharma Corp. - Forward Looking Presentation for Year 2011

  • Company report
  • December 2011
  • 18 pages

... clinical trial accounting we record clinical trial expenses relating to service agreements with various contract research organizations, investigators and other service providers which conduct certain ...

  • Industries: Drug Discovery and Development
  • Countries: United States, North America, Canada

Investor presentation: Pathology in North America for Year 2011

  • Company report
  • November 2011
  • 27 pages
  • by Corporation
  • Industries: Pathology
  • Countries: North America

Drug and Medication Industry in North America

  • Industry report
  • October 2011
  • 2 pages

... Molecule products to lower volume biologicals and therapeutic vaccines. This changing focus may have contributed significantly to some of the shortages we have been seeing. There are opportunities ...

  • Industries: Drug and Medication
  • Countries: United States, North America

Company Report: Drug and Medication in The United States for Year 2011

  • Company report
  • May 2011
  • 9 pages
  • by Corporation

... Or shared ftf opportunity 2) ims mat 12/10 targeting $23.7 Billion2 of total market valuetargeting $5.5 Billion2 of total market value atacand hct (dec)1 avandia (sept) singulair (aug) plavix (may) lexapro ...

  • Industries: Drug and Medication
  • Countries: North America, World, United States

Company Report: Clinical Trial in North America for Year 2011

  • Company report
  • March 2011
  • 3 pages

... Management changes clearly addressing its future as a global operating company. Plant capacity being doubled and expected to be in place by late calendar 2012. Yoplait and nestle clinical trials ...

  • Industries: Drug Discovery and Development
  • Countries: United States, Canada, North America

Company Report: Drug Discovery and Development in North America for Year 2011

  • Company report
  • March 2011
  • 14 pages

... Expected due to a number of factors, including the costs associated with clinical trials, fees from collaborative and license arrangements with third parties and from strategic opportunities. Our cash ...

  • Industries: Drug Discovery and Development
  • Countries: United States, North America, Canada

Investor presentation: Drug and Medication for Year 2011

  • Company report
  • March 2011
  • 24 pages
  • by Corporation
  • Industries: Drug and Medication
  • Countries: World, United States, North America

Company Report: Drug Discovery and Development for Year 2011

  • Company report
  • March 2011
  • 14 pages

... To serve the company in a consulting capacity. 5 Clinical development the following table summarizes recent clinical trials and regulatory developments associated with each of our research ...

  • Industries: Drug Discovery and Development
  • Countries: United States, North America, World

» Purchase Premium Reports (From $ 250 - $ 4 650)

About 200 reports
Latin American Bioinformatics Market by Sector (Agriculture, Molecular Medicine, Research & Animal), Segment (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) & Application (Genomics, Proteomics & Drug Design) - Forecasts to 2017

Latin American Bioinformatics Market by Sector (Agriculture, Molecular Medicine, Research & Animal), Segment (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) & Application (Genomics, Proteomics & Drug Design) - Forecasts to 2017

  • $ 4 650
  • Industry report
  • March 2014
  • by MarketsandMarkets

Bioinformatics is an integration of informatics and life sciences. It uses information technology, statistics, and algorithms for storing, retrieving, and analyzing biological data that is generated during ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.